Skip to main content

Table 1 Population description at baseline

From: Efficacy and pharmacokinetics of betaine in CBS and cblC deficiencies: a cross-over randomized controlled trial

Patient number

Disease

Sex

Age at diagnosis

Age at study (years)

Betaine (mg/kg/days) at inclusion

1

pnrCBS

M

6.8 y

14.41

76.3

2

pnrCBS

F

2.1 y

9.62

107.5

3

cblC

F

3 w

3.62

137.9

4

cblC

M

18 d

4.22

88.9

5

cblC

F

3 w

9.35

190.7

6

cblC

M

1 m

17.8

150.9

7

cblC

M

2 m

6.55

272.1

8

pnrCBS

M

4.1 y

13.4

92.6

9

pnrCBS

M

3.2 y

6.78

160.0

10

pnrCBS

F

6.8 y

13.25

80.5

11

cblC

M

1 m

1.46

94.3

  1. M: Male; F: female; d: days; w: weeks; m: months; y: years